bobg.jpgRobert Goldberg, Ph.D

Robert Goldberg is Vice President and co-founder of the Center for Medicine in the Public Interest (, a non-profit organization that advocates for consumer access to medical innovation, better health information and   personalized healthcare. He is also the founder of CMPI’s Value of Medical Innovation initiative (, which promotes awareness of the value of medical progress, and co-founder of, an online patient-led campaign against practices and policies that deny access to new medicines based on cost.

Dr. Goldberg is also an advisor to several biotech start ups including Myos Corporation, Nanobiosystems and Human Longevity, Inc. Prior to founding CMPI, Goldberg was Director of the Manhattan Institute's Center for Medical Progress and Chairman of its 21st Century FDA Task Force, which examined the impact of the FDA's Critical Path Initiative on drug development and personalized medicine.

His academic research focuses on the value of personalized medicine and medical innovation to longevity, economic growth and well-being. He is the author of “Tabloid Medicine: How the Internet is Being Used To Hijack Medical Science for Fear and Profit.” (Kaplan, 2011)

Dr. Goldberg received his PhD in Politics from Brandeis University in 1984 and is a devoted Yankee fan and father of two children, Sara, 29 and Zach, 26.